1st session: DM locally and worldwide

Session

Chair person: Dr. Nahar Alazmi

Diabetes worldwide overview

Prof. Andrew Boulton

Diabetes in Middle east countries

Dr. Asmus Hammerich

Diabetes in Saudi Arabia

Dr. Khalid Al-Rubeaan

Discussion

Break

Opening ceremony

National anthem

Quran

Opening speech

Dr. Suliman AlShehri

Opening speech

Dr. Nahar Alazmi

Opening speech

His excellency Engr. Fahad Al Jalajel

Honoring

2nd session: Contribution of different sectors in diabetes prevention and control

Session

Chair person: Dr. Nahar Alazmi /Dr. Khaled Alrubian 

Contribution of Health Holding company in diabetes prevention and control

Speaker: CEO of HHC

Contribution of Council of Health Insurance in diabetes prevention and control

Speaker: S.G of CHI

Contribution of Public Health Authority in diabetes prevention and control

Speaker: CEO of PHA

Contribution of SDAIA in diabetes prevention and control

Speaker: CEO of SDAIA

Discussion

Break & Prayer

3rd session: pre-Diabetes and obesity

Session

Chair person: Dr.Suliman Alshehri/ Dr .Raed Aldahash

Pre-diabetes, diagnosis and management

Rashid Aljawair

Pharmacotherapy for Obesity

Dr. Robert Kushner

Women and Obesity

Dr. Enas Shaltot

Discussion

4th session: Diabetes guidelines

Session

Chair person: Dr.Atallah Alruhaili / Dr.yusef Alsaleh

Evolution of the ADA Guidelines on Pharmacotherapy of T2D over the recent years

Dr. Rita Kalyani

What special about Saudi guidelines

Winning center ( Exchange of experiences among GCC diabetes centers )

Speaker: Winning center director

Discussion

lunch

1st session : Complication of Diabetes

Session

Chair person: Prof. Abdulrahman Alshiekh /Dr. Fahad Alsabaan

DKA and hyperosmolar state management: message from expert

Hypoglycemia: A herder for a good control

Dr. Abdulmajeed Alharbi

Time in Range and Diabetes Complications

Dr. Nicholas Argento

Cardiovascular risk stratification in Diabetes

The Glycemia Risk: A Composite Metric for Interpreting the Quality of a CGM Tracing

General discussion & Recommendation

2nd session : New updates in type 2 diabetes

Chair person: Dr.khaled Alabdelkarem /Dr.Saad Alzahrani

Long acting GLP1 agonists vs SGLT2 antagonists risks and benefits

Update in type 2 diabetes management

Discussion

1st session : Updates In Type 1 DM and stem cell transplantation in diabetes management

Chair person: Dr.  Waleed Hashim/ Dr. Saud Alsefri

Overview of type 1 Diabetes

Different insulin regimes in management of type 1 diabetes: cons and pros

Adjunctive non-insulin therapy in type 1 diabetes

Stem cell transplantation where we are after 100 years on insulin

Discussion

2nd session: New updates in type 2 diabetes

Session

Chair person : Dr Nasser Aljohani/ Dr.Afaf Alshammary

Long term remission from type 2 diabetes after bariatric surgery

Session

Arabic Association for the Study of Diabetes and Metabolism (AASD)

Aging & Diabetes

One weekly insulin

Dr. Khaled Alshali

The 5 Ds ( about diabetes and psychological disorders)

Dr. Enas Shaltot

Screening Diabetic Retinopathy Thru A.I.

Dr.Salwa Alhazaa

Discussion

3rd session : Technology & Diabetes

Session

Chair person: Dr.  Mohammed Aldwish / Dr.Badi Alenezy

Saudi Arabian robotic assistance for diabetes

Dr. Mohammed Alotaibi

diabetes technology (CGM) for glycemic monitoring in advanced CKD (stage IV and dialysis)

Pump therapy: where are we?

Dr. Mohammed Aldubayee

What is next after automated close loop

Dr. Mohammed Aldubayee

Discussion

4th session : Technology & Diabetes

Session

Chair person: Dr. Mohammed Ali Batais / Dr. Anwar Aljamah

Social media impact on Diabetes management

Dr. Badi Alenezy

Use of technology in management: what’s new

Dr. Mohammed Alsofiani

use of diabetes technology in the hospital

Closing the forum